Aug 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Precigen and Transdigm Group, on Friday.
HIGHLIGHTS
* Applied Materials Inc AMAT.O: JP Morgan raises target price to $220 from $210 |
* GE Vernova Inc GEV.N: Jefferies raises target price to $658 from $620 |
* MYR Group Inc MYRG.O: Jefferies initiates coverage with hold rating; target price $202 |
* Precigen Inc PGEN.O: JP Morgan raises to neutral from underweight |
* Transdigm Group Inc TDG.N: TD Cowen cuts target price to $1,565 from $1,650 |
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.
* Abeona Therapeutics Inc ABEO.O: Oppenheimer raises target price to $20 from $19 |
* Advance Auto Parts Inc AAP.N: Morgan Stanley raises target price to $55 from $48 |
* Advance Auto Parts Inc AAP.N: RBC raises target price to $60 from $44 |
* Advance Auto Parts Inc AAP.N: Truist Securities raises target price to $53 from $51 |
* Advance Auto Parts Inc AAP.N: Wells Fargo raises target price to $50 from $45 |
* Advanced Flower Capital Inc AFCG.O: Alliance Global Partners cuts to neutral from buy |
* Advanced Flower Capital Inc AFCG.O: Alliance Global Partners cuts PT to $4.5 from $10 |
* Apa Corporation APA.O: Wells Fargo raises target price to $21 from $20 |
* Applied Industrial Technologies Inc AIT.N: Oppenheimer raises target to $300 from $290 |
* Applied Industrial Technologies Inc AIT.N: Raymond James cuts to market perform from outperform |
* Applied Materials Inc AMAT.O: Deutsche Bank cuts target price to $170 from $200 |
* Applied Materials Inc AMAT.O: Berenberg cuts target price to $240 from $250 |
* Applied Materials Inc AMAT.O: BofA Global Research cuts price objective to $180 from $190 |
* Applied Materials Inc AMAT.O: BofA Global Research cuts to neutral from buy |
* Applied Materials Inc AMAT.O: Citigroup cuts target price to $205 from $220 |
* Applied Materials Inc AMAT.O: JP Morgan raises target price to $220 from $210 |
* Applied Materials Inc AMAT.O: Mizuho cuts target price to $200 from $220 |
* Applied Materials Inc AMAT.O: Morgan Stanley raises target price to $172 from $169 |
* Applied Materials Inc AMAT.O: Stifel cuts target price to $180 from $195 |
* Applied Materials Inc AMAT.O: TD Cowen cuts target price to $200 from $220 |
* Applied Materials Inc AMAT.O: UBS cuts target price to $180 from $185 |
* Applied Materials Inc AMAT.O: Wells Fargo cuts target price to $205 from $215 |
* Applied Materials Inc AMAT.O: Morgan Stanley raises target price to $172 from $169 |
* Arhaus Inc ARHS.O: Stifel raises target price to $14 from $10 |
* AZZ Inc AZZ.N: Jefferies raises target price to $141 from $129 |
* Bat BTI.N: Morgan Stanley raises target price to $40 from $35.50 |
* Bioxcel Therapeutics Inc BTAI.O: H.C. Wainwright raises target price to $10 from $8 |
* Block Inc XYZ.N: Jefferies cuts target price to $90 from $95 |
* Broadstone Net Lease Inc BNL.N: UBS raises target price to $17 from $16 |
* BTCS Inc BTCS.O: H.C. Wainwright raises target price to $7 from $5 |
* Celcuity Inc CELC.O: Jefferies raises target price to $79 from $54 |
* Celcuity Inc CELC.O: Needham cuts target price to $70 from $74 |
* CF Industries Holdings Inc CF.N: JP Morgan cuts target price to $87 from $92 |
* Charles Schwab Corp SCHW.N: Truist Securities raises target price to $112 from $107 |
* Chord Energy Corp CHRD.O: Wells Fargo raises target price to $146 from $143 |
* Cisco CSCO.O: HSBC cuts to hold from buy; cuts target price to $69 from $73 |
* Coinbase Global Inc COIN.O: Barclays raises target price to $365 from $352 |
* Consolidated Edison ED.N: BofA Global Research cuts price objective to $101 from $112 |
* Consolidated Edison ED.N: BofA Global Research cuts to underperform from buy |
* Deere & Co DE.N: Daiwa Capital Markets cuts target price to $565 from $597 |
* Deere & Co DE.N: JP Morgan cuts target price to $500.00 from $530.00 |
* Deere & Co DE.N: Oppenheimer raises target price to $566 from $560 |
* Deere & Co DE.N: Truist Securities cuts target price to $602 from $619 |
* Dillard's Inc DDS.N: JP Morgan cuts target price to $443 from $458 |
* Dillard's Inc DDS.N: UBS raises target price to $175 from $170 |
* Editas Medicine, Inc. EDIT.O: H.C. Wainwright raises target price to $5 from $3 |
* Elevance Health ELV.N: Wells Fargo cuts target price to $330 from $400 |
* EPR Properties EPR.N: UBS cuts target price to $54 from $62 |
* Essential Properties Realty Trust Inc EPRT.N: UBS raises target price to $38 from $36 |
* Essential Utilities Inc WTRG.N: UBS raises target price to $47 from $42 |
* Evolv Technologies Holdings Inc EVLV.O: TD Cowen reinstates coverage with buy rating |
* Evolv Technologies Holdings Inc EVLV.O: TD Cowen reinstates coverage with PT $10 |
* Eyepoint Pharmaceuticals Inc EYPT.O: Mizuho raises target price to $28 from $26 |
* Four Corners Property Trust Inc FCPT.N: UBS raises target price to $31 from $30 |
* GE Vernova Inc GEV.N: Jefferies raises target price to $658 from $620 |
* Getty Realty Corp GTY.N: UBS raises target price to $30 from $28 |
* Hyatt Hotels Corp H.N: Jefferies raises target price to $144 from $135 |
* Intuit Inc INTU.O: Citigroup raises target price to $815 from $789 |
* J.M. Smucker SJM.N: Deutsche Bank raises target price to $115 from $110 |
* Jasper Therapeutics Inc JSPR.O: UBS cuts target price to $25 from $29 |
* Kennametal Inc KMT.N: UBS raises target price to $21 from $19 |
* Kennametal Inc KMT.N: UBS raises to neutral from sell |
* Kodiak Sciences Inc KOD.O: Barclays raises target price to $7 from $4 |
* Landbridge Co Llc LB.N: Piper Sandler cuts target price to $55 from $70 |
* Liquidia Corp LQDA.O: Jefferies assumes coverage with buy rating; price target $43 |
* Lm Funding America Inc LMFA.O: H.C. Wainwright raises to buy from neutral |
* Molina Healthcare Inc MOH.N: Wells Fargo cuts target price to $198 from $216 |
* MSC Income Fund Inc MSIF.N: Truist Securities cuts target price to $19 from $20 |
* MYR Group Inc MYRG.O: Jefferies initiates coverage with hold rating; target price $202 |
* National Health Investors Inc NHI.N: Truist Securities raises target to $81 from $77 |
* Netstreit Corp NTST.N: UBS raises target price to $21 from $20 |
* NNN REIT Inc NNN.N: UBS raises target price to $44 from $42 |
* Noodles & Co NDLS.O: Benchmark cuts to hold from buy |
* Oracle Corp ORCL.N: Mizuho raises target price to $300 from $245 |
* Palvella Therapeutics Inc PVLA.O: TD Cowen raises target price to $65 from $44 |
* Palvella Therapeutics Inc. PVLA.O: H.C. Wainwright raises target price to $75 from $38 |
* Papa John's International Inc PZZA.O: Stifel raises target price to $42 from $38 |
* Peakstone Realty Trust PKST.N: UBS raises target price to $16 from $15 |
* Perpetua Resources Corp. PPTA.O: H.C. Wainwright raises target price to $30 from $27.50 |
* Precigen Inc PGEN.O: JP Morgan raises to neutral from underweight |
* Precigen Inc PGEN.O: H.C. Wainwright raises target price to $8.5 from $6 |
* Realty Income Corp O.N: UBS raises target price to $66 from $62 |
* Revolution Medicines Inc RVMD.O: Wells Fargo initiates coverage with overweight rating |
* Revolution Medicines Inc RVMD.O: Wells Fargo initiates coverage with price target $67 |
* Ryman Hospitality Properties Inc RHP.N: Jefferies cuts target price to $111 from $115 |
* Sandisk Corp SNDK.O: Benchmark raises target price to $70 from $62 |
* Sandisk Corp SNDK.O: Wells Fargo raises target price to $50 from $45 |
* Sarepta Therapeutics, Inc. SRPT.O: Deutsche Bank raises target price to $12 from $6 |
* Savara Inc SVRA.O: Oppenheimer raises target price to $6 from $5 |
* Savara Inc SVRA.O: H.C. Wainwright raises target price to $5 from $2 |
* Schrodinger Inc SDGR.O: Barclays cuts target price to $24 from $25 |
* Schrodinger Inc SDGR.O: Citigroup cuts to neutral from buy; cuts PT to $20 from $35 |
* Spire Inc SR.N: BofA Global Research cuts price objective to $76 from $81 |
* Spire Inc SR.N: BofA Global Research cuts to underperform from neutral |
* SSR Mining Inc SSRM.O: UBS raises to buy from neutral |
* SSR Mining Inc SSRM.O: UBS raises target price to $18.95 from $13.85 |
* Starz Entertainment Corp. STRZ.O: Morgan Stanley cuts target price to $14 from $15 |
* Stoke Therapeutics Inc STOK.O: Canaccord Genuity raises target price to $24 from $20 |
* Synovus Financial Corp SNV.N: Citigroup cuts target price to $63 from $65 |
* Tapestry Inc TPR.N: Barclays raises target price to $111 from $105 |
* Tapestry Inc TPR.N: Jefferies cuts target price to $120 from $123 |
* Tapestry Inc TPR.N: JP Morgan cuts target price to $139 from $145 |
* Tapestry Inc TPR.N: UBS cuts target price to $105 from $112 |
* Tapestry Inc TPR.N: Wells Fargo raises target price to $120 from $100 |
* Target Corp TGT.N: BofA Global Research cuts price objective to $93 from $105 |
* Target Corp TGT.N: BofA Global Research cuts to underperform from neutral |
* Target Corp TGT.N: Mizuho raises target price to $94 from $88 |
* Terawulf Inc WULF.O: Northland Capital raises target price to $12 from $10 |
* TKO Group TKO.N: Citigroup raises target price to $225 from $200 |
* Trade Desk Inc TTD.O: UBS cuts target price to $80 from $105 |
* Transdigm Group Inc TDG.N: TD Cowen cuts target price to $1,565 from $1,650 |
* Ulta Beauty Inc ULTA.O: Wells Fargo raises target price to $400 from $350 |
* Williams Companies Inc WMB.N: CIBC raises to outperform from neutral |
* Williams Companies Inc WMB.N: CIBC raises target price to $64 from $61 |
* Williams-Sonoma Inc WSM.N: Barclays raises target price to $180 from $166 |
* Wingstop Inc WING.O: Raymond James raises to strong buy from outperform |
* WP Carey Inc WPC.N: UBS raises target price to $68 from $63 |
* Zura Bio Limited ZURA.O: Oppenheimer cuts target price to $16 from $17 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.